tSCS in Children With Spina Bifida
2026年9月11日 更新者:Bailey Petersen
Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida
A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.
研究概览
地位
地位
招聘中
干预/治疗
干预/治疗
详细说明
Transcutaneous, or non-invasive, spinal cord stimulation (tSCS) has been effective at improving motor control, especially walking, in adults with a variety of neuromuscular disorders and in children with spinal cord injury.
Children with spina bifida often have similar difficulties with walking, muscle strength and bladder control throughout their lives, with few effective therapies to reliably improve walking.
In this pilot, the investigators will test if tSCS can improve motor deficits and bladder control in children with spina bifida.
The investigators are enrolling up to 20 subjects with myelomeningocele, ages 4-17 years old, that have some difficulty walking but can walk for even short distances with assistance, and that have bladder dysfunction with a stable bladder regimen.
Over 4-6 weeks, children will have stimulation using non-invasive tSCS electrodes placed on their low back.
Similar protocols have been used for tSCS in children with spinal cord injury and children with cerebral palsy.
All previous tSCS studies have shown that this is a safe technology for use with pediatric populations.
This pilot study will be used to refine the design of future randomized controlled trials to test tSCS over standard physical therapy care.
研究类型
研究类型
介入性
注册 (估计的)
注册
20
阶段
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
学习联系方式
- 姓名:Sydney Bader, MS
- 电话号码:412-648-4196
- 邮箱:syb17@pitt.edu
学习地点
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、美国、15213
- 招聘中
- University of Pittsburgh
-
接触:
- Sydney Bader, MS
- 邮箱:syb17@pitt.edu
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
资格标准
适合学习的年龄
- 孩子
接受健康志愿者
不
描述
Inclusion Criteria:
- Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
- Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
- Between the ages of 4 and 17 years of age.
- Documented neurogenic bladder dysfunction
- On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial
Exclusion Criteria:
- Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.
- Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.
- Is pregnant. Pregnancy will be assessed via verbal report.
- Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.
- Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps)
- Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
手臂数量
1
武器和干预
参与者组/臂参与者组/臂 |
干预/治疗干预/治疗 |
|---|---|
|
实验性的:Transcutaneous SCS
All participants will be receiving transcutaneous spinal cord stimulation
|
an off the shelf TENS unit or Digitimer DS8R (using same parameters as TENS unit)
|
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Muscle Strength
大体时间:4-6 weeks
|
change in isometric torque of quadriceps during knee extension
|
4-6 weeks
|
|
Gait Kinematics
大体时间:4-6 weeks
|
Change in joint angles in tSCS vs no stim conditions
|
4-6 weeks
|
|
Bladder capacity
大体时间:4-6 weeks
|
Change in cystometric bladder capacity with tSCS vs no stim conditions
|
4-6 weeks
|
|
Gait Kinetics
大体时间:4-6 weeks
|
Changes in ground reaction forces with and without stimulation
|
4-6 weeks
|
|
Bladder Pressure
大体时间:4-6 weeks
|
Change in voiding pressure with tSCS vs no stim conditions
|
4-6 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
调查人员
- 首席研究员:Bailey Petersen, PhD、University of Pittsburgh
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Keller A, Singh G, Sommerfeld JH, King M, Parikh P, Ugiliweneza B, D'Amico J, Gerasimenko Y, Behrman AL. Noninvasive spinal stimulation safely enables upright posture in children with spinal cord injury. Nat Commun. 2021 Oct 6;12(1):5850. doi: 10.1038/s41467-021-26026-z.
- Amirova L, Keller A, Singh G, King M, Parikh P, Stepp N, Ugiliweneza B, Gerasimenko Y, Behrman AL. Cumulative Transcutaneous Spinal Stimulation with Locomotor Training Safely Improves Trunk Control in Children with Spinal Cord Injury: Pilot Study. Children (Basel). 2025 Jun 21;12(7):817. doi: 10.3390/children12070817.
- Neighbors E, Brunn L, Casamento-Moran A, Martin R. Transcutaneous Spinal Cord Stimulation Enables Recovery of Walking in Children with Acute Flaccid Myelitis. Children (Basel). 2024 Sep 12;11(9):1116. doi: 10.3390/children11091116.
- Hastings S, Zhong H, Feinstein R, Zelczer G, Mitrovich C, Gad P, Edgerton VR. A pilot study combining noninvasive spinal neuromodulation and activity-based neurorehabilitation therapy in children with cerebral palsy. Nat Commun. 2022 Oct 5;13(1):5660. doi: 10.1038/s41467-022-33208-w.
- Danielsson AJ, Bartonek A, Levey E, McHale K, Sponseller P, Saraste H. Associations between orthopaedic findings, ambulation and health-related quality of life in children with myelomeningocele. J Child Orthop. 2008 Feb;2(1):45-54. doi: 10.1007/s11832-007-0069-6. Epub 2007 Dec 15.
- McCoy AR, Singerman L, Anand N, Kanallakan A. Spina Bifida. Phys Med Rehabil Clin N Am. 2025 Aug;36(3):513-530. doi: 10.1016/j.pmr.2025.03.003. Epub 2025 May 29.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
学习开始
2026年9月30日
初级完成 (估计的)
初级完成
2028年3月10日
研究完成 (估计的)
研究完成
2029年3月10日
研究注册日期
首次提交
首次提交
2026年5月22日
首先提交符合 QC 标准的
首先提交符合 QC 标准的
2026年5月22日
首次发布 (实际的)
首次发布
2026年5月29日
研究记录更新
最后更新发布 (实际的)
最后更新发布
2026年9月15日
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
2026年9月11日
最后验证
最后验证
2026年9月1日
更多信息
与本研究相关的术语
其他研究编号
其他研究编号
- STUDY25100066
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
是的
IPD 计划说明
De-identified individual participant data collected during the trial may be shared with other researchers for the purpose of data analysis and collaboration.
IPD 共享时间框架
Data will become available at the end of the trial upon publication of the first manuscript.
IPD 共享访问标准
Data must be directly requested to the PI and will be shared upon completion of necessary data sharing agreement to protect confidential patient information.
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
- 分析代码
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
是的
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.